Edition:
India

BTG PLC (BTG.L)

BTG.L on London Stock Exchange

592.00GBp
29 Apr 2016
Change (% chg)

-11.00p (-1.82%)
Prev Close
603.00p
Open
601.00p
Day's High
604.00p
Day's Low
586.00p
Volume
513,239
Avg. Vol
666,549
52-wk High
806.90p
52-wk Low
504.00p

BTG.L

Chart for BTG.L

About

BTG plc is a specialist healthcare company. The Company operates in three business segments: Interventional Medicine (IM) (oncology, vascular and pulmonology products), Specialty Pharmaceuticals (antidote products) and Licensing (royalties from licensed assets). The Company's Interventional Medicine segment offers a portfolio of... (more)

Overall

Beta: 0.37
Market Cap(Mil.): £2,309.44
Shares Outstanding(Mil.): 382.99
Dividend: --
Yield (%): --

Financials

  BTG.L Industry Sector
P/E (TTM): 51.46 33.80 45.25
EPS (TTM): 0.12 -- --
ROI: 5.65 13.05 12.52
ROE: 6.59 13.77 13.42
Search Stocks

BTG boss scans for next deals as lung device bet pays off

LONDON After being vindicated in her 2014 purchase of a U.S. company with a device to prop open diseased lungs, the chief executive of British healthcare group BTG is scouring the horizon for the next promising acquisition.

17 Dec 2015

BTG gets triple dose of good news on new products

LONDON Specialist medicine company BTG received a triple dose of good news on Monday as U.S. regulators approved two new treatments and a clinical trial of a novel lung device produced positive results.

14 Dec 2015

BRIEF-BTG H1 revenue climbs 20 pct

* Operating profit before acquisition adjustments and reorganisation costs was £62.9m (h1 14/15: £56.8m)

10 Nov 2015

Earnings vs. Estimates

Search Stocks